Related Experiment Videos
[Problems of current antidepressant drugs].
1Department of Psychiatry, National Defense Medical College, 3-2, Namiki, Tokorozawa, 359-8513 Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|May 24, 2003
Summary
Current antidepressants offer limited improvement for mood disorders. New strategies are needed to overcome issues like modest efficacy and side effects for better treatment outcomes.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Context:
- 17 antidepressant medications are approved in Japan.
- Existing drugs, including SSRIs and SNRIs, demonstrate clinical efficacy.
- Despite widespread use, significant advancements in mood disorder treatment outcomes remain limited.
Purpose:
- To highlight the limitations of current antidepressant pharmacotherapy.
- To underscore the need for novel antidepressant development strategies.
Summary:
- Current antidepressants, such as SSRIs and SNRIs, exhibit a 60-70% efficacy rate.
- These drugs often lack immediate onset of action and can cause side effects.
- Predicting individual drug efficacy and achieving pleasant effects remain challenging.
Impact:
- The common prototypes of existing antidepressants contribute to their shared shortcomings.
- A new strategic approach is crucial for developing more effective antidepressant therapies.